Meridian Bioscience Inc (VIVO) Gross Profit Margin starting from the first quarter 2022 to first quarter 2021, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Meridian Bioscience Inc   (NASDAQ: VIVO)


Meridian Bioscience Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VIVO Gross Profit Margin (Dec 31 2022)
Q1 		(Sep 30 2022)
Q4 		(Jun 30 2022)
Q3 		(Mar 31 2022)
Q2 		(Dec 31 2021)
Q1
Y / Y Revenue Change -35.59 %
Seq. Revenue Change -13.36 %
Revenue In Millions $56.90
Gross Profit Margin 55.37 %
Gross Profit Margin Total Ranking # 1383
Gross Profit In Millions $31.51
Y / Y Gross Profit Change -35.91 %
Seq. Gross Profit Change -7.32 %


Commenting First Quarter 2022 Gross Profit Margin
Meridian Bioscience Inc increased Gross Profit Margin through reduction in Cost of Sales and despite contraction in Gross Profit by -7.32 % and Revenue by -13.36 %. Gross Profit Margin in Q1 was 55.37 %, below company average.


Observing first quarter 2022 results within In Vitro & In Vivo Diagnostic Substances industry 3 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 1383, from total ranking in the previous quarter at 1703.
Learn about Gross Margin
VIVO's Gross Profit Margin first quarter 2022 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 4
Healthcare Sector # 274
Overall # 1357

Gross Profit Margin Statistics
High Average Low
67.76 % 61.53 % 51.76 %
(Mar 31 2021)   (Sep 30 2022)


VIVO Gross Income Trends • More of VIVO's Profitabilty Ratios • VIVO Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
VIVO's Cumulative Gross Profit Margin
In Vitro & In Vivo Diagnostic Substances Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
VIVO's Gross Profit Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for VIVO's Competitors
Gross Profit Margin Profit Margin for Meridian Bioscience Inc 's Suppliers
Gross Profit Margin Profit Margin for VIVO's Customers

You may also want to know
VIVO's Annual Growth Rates VIVO's Profitability Ratios VIVO's Asset Turnover Ratio VIVO's Dividend Growth
VIVO's Roe VIVO's Valuation Ratios VIVO's Financial Strength Ratios VIVO's Gross Profit Growth
VIVO's Roa VIVO's Inventory Turnover Ratio VIVO's Growth Rates VIVO's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2022, within In Vitro & In Vivo Diagnostic Substances Industry Gross Profit MarginDec 31 2022 MRQ Gross ProfitDec 31 2022 MRQ Revenue
Myriad Genetics Inc   69.69 %$ 123.900  Millions$ 177.800  Millions
Quotient Limited  66.85 %$ 6.050  Millions$ 9.050  Millions
Lantheus Holdings Inc   63.52 %$ 167.171  Millions$ 263.166  Millions
Idexx Laboratories Inc  58.53 %$ 484.927  Millions$ 828.568  Millions
Aspira Women s Health inc   57.59 %$ 1.240  Millions$ 2.153  Millions
Meridian Bioscience Inc   55.37 %$ 31.505  Millions$ 56.902  Millions
Quidelortho Corp  52.05 %$ 451.042  Millions$ 866.541  Millions
Neogen Corporation  48.92 %$ 112.539  Millions$ 230.033  Millions
Heska Corporation  41.93 %$ 27.818  Millions$ 66.338  Millions
Trinity Biotech Plc  29.48 %$ 22.048  Millions$ 74.779  Millions
Alpha Teknova Inc   26.74 %$ 2.110  Millions$ 7.891  Millions
Immucell Corporation  25.37 %$ 0.992  Millions$ 3.911  Millions
Biomerica Inc   23.74 %$ 0.352  Millions$ 1.482  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.